This Event is licensed under the Creative Commons BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.

Event: 2319

Key Event Title

A descriptive phrase which defines a discrete biological change that can be measured. More help

Decreased, Pregnenolone levels

Short name
The KE short name should be a reasonable abbreviation of the KE title and is used in labelling this object throughout the AOP-Wiki. More help
Decreased, Pregnenolone levels
Explore in a Third Party Tool

Biological Context

Structured terms, selected from a drop-down menu, are used to identify the level of biological organization for each KE. More help
Level of Biological Organization
Tissue

Organ term

The location/biological environment in which the event takes place.The biological context describes the location/biological environment in which the event takes place.  For molecular/cellular events this would include the cellular context (if known), organ context, and species/life stage/sex for which the event is relevant. For tissue/organ events cellular context is not applicable.  For individual/population events, the organ context is not applicable.  Further information on Event Components and Biological Context may be viewed on the attached pdf. More help

Key Event Components

The KE, as defined by a set structured ontology terms consisting of a biological process, object, and action with each term originating from one of 14 biological ontologies (Ives, et al., 2017; https://aopwiki.org/info_pages/2/info_linked_pages/7#List). Biological process describes dynamics of the underlying biological system (e.g., receptor signalling).Biological process describes dynamics of the underlying biological system (e.g., receptor signaling).  The biological object is the subject of the perturbation (e.g., a specific biological receptor that is activated or inhibited). Action represents the direction of perturbation of this system (generally increased or decreased; e.g., ‘decreased’ in the case of a receptor that is inhibited to indicate a decrease in the signaling by that receptor).  Note that when editing Event Components, clicking an existing Event Component from the Suggestions menu will autopopulate these fields, along with their source ID and description.  To clear any fields before submitting the event component, use the 'Clear process,' 'Clear object,' or 'Clear action' buttons.  If a desired term does not exist, a new term request may be made via Term Requests.  Event components may not be edited; to edit an event component, remove the existing event component and create a new one using the terms that you wish to add.  Further information on Event Components and Biological Context may be viewed on the attached pdf. More help

Key Event Overview

AOPs Including This Key Event

All of the AOPs that are linked to this KE will automatically be listed in this subsection. This table can be particularly useful for derivation of AOP networks including the KE.Clicking on the name of the AOP will bring you to the individual page for that AOP. More help

Taxonomic Applicability

Latin or common names of a species or broader taxonomic grouping (e.g., class, order, family) that help to define the biological applicability domain of the KE.In many cases, individual species identified in these structured fields will be those for which the strongest evidence used in constructing the AOP was available in relation to this KE. More help
Term Scientific Term Evidence Link
mammals mammals High NCBI

Life Stages

An indication of the the relevant life stage(s) for this KE. More help
Life stage Evidence
All life stages High

Sex Applicability

An indication of the the relevant sex for this KE. More help
Term Evidence
Mixed High

Key Event Description

A description of the biological state being observed or measured, the biological compartment in which it is measured, and its general role in the biology should be provided. More help

Pregnenolone is the precursor for all steroid hormones and its expression and conversion depends on tissue and cell type, as well as availability and activity of various steroid enzymes. Pregnenolone is expressed in all tissues with steroidogenic activity, where it is converted from cholesterol by cytochrome P-450 enzyme (P450scc or CYP11A1) in the inner mitochondrial membrane and exits the mitochondria to be available for production of downstream steroid hormones (DM et al., 2017). Pregnenolone has other roles besides being the precursor to all steroids. For example, expression of 

pregnenolone in the brain is essential for cognitive functions, regulation of neurotransmission, is an important neuromodulator, and is neuroprotective (Lin et al., 2022; Vallée, 2016). 

Pregnenolone can be converted into 17-OH pregnenolone by CYP17A1 (expressed mainly in gonads and adrenal cortex in humans (Z et al., 2019)) or progesterone by 3-beta-hydroxysteroid dehydrogenase (3-beta-HSD) (membrane-bound enzyme (Q et al., 2019)). 

Two main pathways, Δ4 in rodents, hamsters and guinea pigs and Δ5 in humans and bovine, both in other species, can determine what downstream hormones will be synthesized from pregnenolone (Flück et al., 2003). Pregnenolone is converted to progesterone by 3-beta-HSD then to 17-OH-progesterone and androstenedione by CYP17A1 enzyme for the Δ4 pathway. More commonly in humans, pregnenolone is converted to 17-OH-pregnenolone and to dehydroepiandrosterone (DHEA), by CYP17A1, following the Δ5 pathway (Z et al., 2019). 

Reduction of pregnenolone synthesis, or inhibition of CYP11A1 for example, can lead to a decrease in pregnenolone levels. This will impact all of steroidogenesis as all downstream steroid hormones are synthesized from pregnenolone.

How It Is Measured or Detected

A description of the type(s) of measurements that can be employed to evaluate the KE and the relative level of scientific confidence in those measurements.These can range from citation of specific validated test guidelines, citation of specific methods published in the peer reviewed literature, or outlines of a general protocol or approach (e.g., a protein may be measured by ELISA). Do not provide detailed protocols. More help

There is no standardised test guideline available for the measurement of pregnenolone. However, the H295R cell line can be used in a high throughput assay to measure pregnenolone using LC-MS/MS (Haggard et al., 2018; Karmaus et al., 2016). LC-MS/MS has also been used recently to measure steroid hormones including pregnenolone in rat plasma and tissue (Evangelista et al., 2024). ELISA or RIA immunoassays can be used to measure tissue or serum levels of pregnenolone.

Domain of Applicability

A description of the scientific basis for the indicated domains of applicability and the WoE calls (if provided).  More help

Taxonomic applicability. 

Pregnenolone is conserved from amphibians to mammals, even plants (Batth et al., 2020; DM et al., 2017; Tarkowská, 2019; V et al., 2018), but in the case of this KER, it is focused on mammals. 

Life stage applicability 

It is also applicable for all life stages as it plays roles during development and adulthood (DM et al., 2017; V et al., 2018). 

Sex applicability 

Both sexes produce pregnenolone as it is the precursor to all other steroid hormones necessary for correct development, reproduction and general homeostasis (DM et al., 2017; V et al., 2018).

References

List of the literature that was cited for this KE description. More help

Batth, R., Nicolle, C., Cuciurean, I. S., & Simonsen, H. T. (2020). Biosynthesis and Industrial Production of Androsteroids. Plants, 9(9), 1144. https://doi.org/10.3390/plants9091144 

DM, S., AH, Z., LN, T., K, M., & V, S. (2017). A brief history of the search for the protein(s) involved in the acute regulation of steroidogenesis. Molecular and Cellular Endocrinology, 441, 7–16. https://doi.org/10.1016/j.mce.2016.07.036 

Evangelista, S., Vazakidou, P., Koekkoek, J., Heinzelmann, M. T., Lichtensteiger, W., Schlumpf, M., Tresguerres, J. A. F., Linillos-Pradillo, B., van Duursen, M. B. M., Lamoree, M. H., & Leonards, P. E. G. (2024). High throughput LC-MS/MS method for steroid hormone analysis in rat liver and 

plasma – unraveling methodological challenges. Talanta, 266, 124981. https://doi.org/10.1016/j.talanta.2023.124981 

Flück, C. E., Miller, W. L., & Auchus, R. J. (2003). The 17, 20-Lyase Activity of Cytochrome P450c17 from Human Fetal Testis Favors the Δ 5 Steroidogenic Pathway. The Journal of Clinical Endocrinology & Metabolism, 88(8), 3762–3766. https://doi.org/10.1210/jc.2003-030143 

Haggard, D. E., Karmaus, A. L., Martin, M. T., Judson, R. S., Setzer, R. W., & Paul Friedman, K. (2018). High-Throughput H295R Steroidogenesis Assay: Utility as an Alternative and a Statistical Approach to Characterize Effects on Steroidogenesis. Toxicological Sciences, 162(2), 509–534. https://doi.org/10.1093/toxsci/kfx274 

Karmaus, A. L., Toole, C. M., Filer, D. L., Lewis, K. C., & Martin, M. T. (2016). High-Throughput Screening of Chemical Effects on Steroidogenesis Using H295R Human Adrenocortical Carcinoma Cells. Toxicological Sciences, 150(2), 323–332. https://doi.org/10.1093/toxsci/kfw002 

Lin, Y. C., Cheung, G., Espinoza, N., & Papadopoulos, V. (2022). Function, regulation, and pharmacological effects of pregnenolone in the central nervous system. Current Opinion in Endocrine and Metabolic Research, 22, 100310. https://doi.org/10.1016/j.coemr.2021.100310 

Q, Z., P, P., X, C., Y, W., S, Z., J, M., X, L., & RS, G. (2019). Human placental 3β-hydroxysteroid dehydrogenase/steroid Δ5,4-isomerase 1: Identity, regulation and environmental inhibitors. Toxicology, 425, 152253. https://doi.org/10.1016/j.tox.2019.152253 

Tarkowská, D. (2019). Plants are Capable of Synthesizing Animal Steroid Hormones. Molecules, 24(14), 2585. https://doi.org/10.3390/molecules24142585 

V, S., DM, S., & BJ, C. (2018). Current knowledge on the acute regulation of steroidogenesis. Biology of Reproduction, 99(1), 13–26. https://doi.org/10.1093/biolre/ioy102 

Vallée, M. (2016). Neurosteroids and potential therapeutics: Focus on pregnenolone. The Journal of Steroid Biochemistry and Molecular Biology, 160, 78–87. https://doi.org/10.1016/j.jsbmb.2015.09.030 

Z, P., G, X., W, C., & S, X. (2019). Environmental inhibitors of the expression of cytochrome P450 17A1 in mammals. Environmental Toxicology and Pharmacology, 69, 16–25. https://doi.org/10.1016/j.etap.2019.02.007